Co-Diagnostics, Inc. short interest in 2020
In 2020, Co-Diagnostics, Inc.'s disclosed short interest ran from 3.47% of shares outstanding on 15 Jan 2020 to 23.10% on 31 Dec 2020, a change of +19.63 percentage points. The year's high was 29.91% on 15 Sep 2020 and its low 3.47% on 15 Jan 2020, averaging 20.71% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.51 days on 31 Dec 2020. Full history: Co-Diagnostics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 3.47% (15 Jan 2020)
- End of year
- 23.10% (31 Dec 2020)
- Change
- +19.63 pp
- High
- 29.91% (15 Sep 2020)
- Low
- 3.47% (15 Jan 2020)
- Average
- 20.71%
- Highest days to cover
- 5.51 (31 Dec 2020)
- SEC filings marked
- 6
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 3.47% | 2.07 | |
| 31 Mar 2020 | 17.29% | 1.00 | 10-K filed |
| 15 Apr 2020 | 17.25% | 1.00 | |
| 30 Apr 2020 | 18.14% | 1.00 | |
| 15 May 2020 | 20.24% | 1.00 | 10-Q filed, results (8-K) |
| 29 May 2020 | 12.99% | 1.00 | |
| 15 Jun 2020 | 11.96% | 1.84 | |
| 30 Jun 2020 | 17.72% | 1.53 | |
| 15 Jul 2020 | 21.85% | 2.90 | |
| 31 Jul 2020 | 22.65% | 1.84 | |
| 14 Aug 2020 | 23.68% | 1.63 | 10-Q filed |
| 31 Aug 2020 | 27.94% | 2.40 | |
| 15 Sep 2020 | 29.91% | 1.16 | |
| 30 Sep 2020 | 24.64% | 3.10 | |
| 15 Oct 2020 | 23.96% | 4.22 | |
| 30 Oct 2020 | 23.01% | 3.93 | |
| 13 Nov 2020 | 24.57% | 4.47 | |
| 30 Nov 2020 | 25.75% | 2.02 | 10-Q filed, results (8-K) |
| 15 Dec 2020 | 24.08% | 5.45 | |
| 31 Dec 2020 | 23.10% | 5.51 |
See also: Co-Diagnostics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.